Cargando…
NZ's Pharmac to fund baricitinib for moderate-to-severe COVID-19
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585731/ https://www.ncbi.nlm.nih.gov/pubmed/34785883 http://dx.doi.org/10.1007/s40274-021-08193-6 |